INTEGRA Biosciences Nordic ApS: Financial statements 2024
CVR: 43279092
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
INTEGRA Biosciences Nordic ApS (CVR 43279092) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,115,411 and a net result of DKK -1,699,859 compared with DKK -956,194 the year before. That is an increase of 41.6% compared with the year before. Equity in the 2024 report amounted to DKK -3,649,436. The company had 6 employees in the financial year.
- Gross Profit
- DKK 4,115,411
- Profit/Loss
- DKK -1,699,859
- Equity
- DKK -3,649,436
- Total Assets
- DKK 11,534,453
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 4.1M | -1.7M | -3.6M | 6 |
| 2023 | - | 2.9M | -956K | -1.9M | 4 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
INTEGRA Biosciences Nordic ApS has published its annual report for 2023. Gross profit came to DKK 2,905,351, and the net result was DKK -956,194.
About INTEGRA Biosciences Nordic ApS
INTEGRA Biosciences Nordic ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2022. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The management consists of Kirsten Thuesen, Sven Karl Linder and Torbjørn Gripp. The company is owned by INTEGRA Biosciences Holding AG. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK 7,117,285 and a net result of DKK 413,813 compared with DKK -1,699,859 the year before. Equity in the 2025 report amounted to DKK -3,235,625.